Publication:
Liver cirrhosis and sarcopenia: a dreadful combination.

dc.contributor.authorKuchay, Mohammad Shafi
dc.contributor.authorMartinez-Montoro, Jose Ignacio
dc.contributor.authorLlamoza-Torres, Camilo Julio
dc.contributor.authorFernandez-Garcia, Jose Carlos
dc.contributor.authorRamos-Molina, Bruno
dc.contributor.funderInstitute of Health Carlos III
dc.date.accessioned2023-05-03T14:32:23Z
dc.date.available2023-05-03T14:32:23Z
dc.date.issued2022-09-05
dc.description.abstractPatients with liver cirrhosis, irrespective of etiology, have increased risk of liver-related and all-cause mortality (1). Also, the severity of cirrhosis determines health outcomes. For instance, patients with compensated cirrhosis have a nearly five-fold increased risk of death, while those with decompensated cirrhosis have approximately a 10-fold increased risk compared with the general population (1). Furthermore, the median survival time of patients with compensated cirrhosis is 12 years, while it is only 1.8 years in those with decompensated cirrhosis (2). Moreover, the presence of intercurrent conditions, such as sarcopenia (loss of skeletal muscle mass and function) may also compromise the prognosis of patients with cirrhosis (3).
dc.description.versionSi
dc.identifier.citationKuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731
dc.identifier.doi10.21037/hbsn-22-355
dc.identifier.issn2304-3881
dc.identifier.pmcPMC9577976
dc.identifier.pmid36268240
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577976/pdf
dc.identifier.unpaywallURLhttps://hbsn.amegroups.com/article/viewFile/101565/pdf
dc.identifier.urihttp://hdl.handle.net/10668/21770
dc.issue.number5
dc.journal.titleHepatobiliary surgery and nutrition
dc.journal.titleabbreviationHepatobiliary Surg Nutr
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number729-731
dc.provenanceRealizada la curación de contenido 15/04/2025
dc.publisherAME Publishing Company
dc.pubmedtypeEditorial
dc.pubmedtypeComment
dc.relation.projectIDPI20/00505
dc.relation.projectIDCP19/00098
dc.relation.publisherversionhttps://doi.org/10.21037/hbsn-22-355
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectFibrosis
dc.subjectSarcopenia
dc.subjectDeath
dc.subjectLiver Cirrhosis
dc.subjectMortality
dc.subject.decsFibrosis
dc.subject.decsMúsculo esquelético
dc.subject.decsHígado
dc.subject.decsPronóstico
dc.subject.decsCirrosis hepática
dc.subject.meshHumans
dc.subject.meshPrognosis
dc.subject.meshMuscle, Skeletal
dc.subject.meshOutcome Assessment, Health Care
dc.titleLiver cirrhosis and sarcopenia: a dreadful combination.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9577976.pdf
Size:
123.35 KB
Format:
Adobe Portable Document Format